We are studying the safety and effectiveness of anifrolumab in children and teens with moderate to severe lupus. This trial aims to find the right dose and see how well it works compared to a placebo.
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the body's immune system mistakenly attacks healthy tissue, leading to inflammation and damage in various organs. Symptoms can vary widely and may include joint pain, skin rashes, fatigue, and fever.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
